Athena Kaporis, MD
Dermatology · Mount Kisco, NYNPI 1861422776
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $6,500 of the $9,748 with a category attached, or 66.7%. AbbVie accounts for 70.4% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $7,291 and has fallen 96.0% since, to $292 in 2025.
Across 59 payments — averaging $165.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$7K
- Galderma Laboratories, L.p.$2K
- Sun Pharmaceutical Industries Inc.$397
- Incyte Corporation$199
- Dermavant Sciences, Inc.$147
- Botanix SB Inc$125
- plus $407 from 4 others
What the payments were for
- Speaking & faculty fees$6,50067%
- Food & beverage$3,23733%
- Education$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 11 | $6,864 |
| Galderma Laboratories, L.p. | 30 | $1,610 |
| Sun Pharmaceutical Industries Inc. | 6 | $397 |
| Incyte Corporation | 3 | $199 |
| Dermavant Sciences, Inc. | 1 | $147 |
| Botanix SB Inc | 1 | $125 |
| Pfizer | 1 | $125 |
| LEO Pharma Inc. | 1 | $125 |
| Amgen | 2 | $93 |
| Merz North America, Inc. | 3 | $64 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX COSMETIC$500
- Winlevi$370
- AKLIEF$253
- EPIDUO FORTE$252
- EPSOLAY$226
- ORACEA$149
- SOOLANTRA$149
- ABSORICA LD$125
- LITFULO$125
- SOFDRA$125
- ADBRY$125
- OPZELURA$122
- TWYNEO$103
How this compares
$9,748 in reported general payments places this provider in the 75th percentile of 1,151 dermatology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 23 | $96,749 |
| Metronidazole | 83 | $4,046 |
| Fluorouracil | 63 | $3,851 |
| Ketoconazole | 150 | $2,665 |
| Clobetasol Propionate | 67 | $2,607 |
| Doxycycline Hyclate | 92 | $2,061 |
| ValacyclovirValacyclovir Hcl | 54 | $1,585 |
| Tretinoin | 25 | $952 |
| Triamcinolone Acetonide | 72 | $831 |
| Fluocinonide | 20 | $695 |
| Clindamycin Phosphate | 16 | $685 |
| Desonide | 16 | $676 |
| Mupirocin | 73 | $535 |
| Mometasone Furoate | 28 | $414 |
| Imiquimod | 12 | $381 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Mount Kisco
- Alexandra GolantNew York$3.6M
- David CohenNew York$3M
- Michael CameronNew York$2.6M
- Saakshi KhattriNew York$2.4M
- Amy WechslerNew York$2.4M
- Jeffrey WeinbergKew Gardens$2.3M
- Joshua ZeichnerNew York$2.1M
- Russell CohenOceanside$2.1M
- Jeffrey LaducaAuburn$1.9M
- Emma GuttmanNew York$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.